Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,658 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women.
Barrett-Connor E, Mosca L, Collins P, Geiger MJ, Grady D, Kornitzer M, McNabb MA, Wenger NK; Raloxifene Use for The Heart (RUTH) Trial Investigators. Barrett-Connor E, et al. Among authors: collins p. N Engl J Med. 2006 Jul 13;355(2):125-37. doi: 10.1056/NEJMoa062462. N Engl J Med. 2006. PMID: 16837676 Free article. Clinical Trial.
Is diabetes mellitus a heart disease equivalent in women? Results from an international study of postmenopausal women in the Raloxifene Use for the Heart (RUTH) Trial.
Daniels LB, Grady D, Mosca L, Collins P, Mitlak BH, Amewou-Atisso MG, Wenger NK, Barrett-Connor E; Raloxifene Use for the Heart (RUTH) Trial Investigators. Daniels LB, et al. Among authors: collins p. Circ Cardiovasc Qual Outcomes. 2013 Mar 1;6(2):164-70. doi: 10.1161/CIRCOUTCOMES.112.966986. Epub 2013 Mar 12. Circ Cardiovasc Qual Outcomes. 2013. PMID: 23481531 Free article. Clinical Trial.
Reduced incidence of invasive breast cancer with raloxifene among women at increased coronary risk.
Grady D, Cauley JA, Geiger MJ, Kornitzer M, Mosca L, Collins P, Wenger NK, Song J, Mershon J, Barrett-Connor E; Raloxifene Use for The Heart Trial Investigators. Grady D, et al. Among authors: collins p. J Natl Cancer Inst. 2008 Jun 18;100(12):854-61. doi: 10.1093/jnci/djn153. Epub 2008 Jun 10. J Natl Cancer Inst. 2008. PMID: 18544744 Free PMC article. Clinical Trial.
Effect of raloxifene on stroke and venous thromboembolism according to subgroups in postmenopausal women at increased risk of coronary heart disease.
Mosca L, Grady D, Barrett-Connor E, Collins P, Wenger N, Abramson BL, Paganini-Hill A, Geiger MJ, Dowsett SA, Amewou-Atisso M, Kornitzer M. Mosca L, et al. Among authors: collins p. Stroke. 2009 Jan;40(1):147-55. doi: 10.1161/STROKEAHA.108.518621. Epub 2008 Oct 23. Stroke. 2009. PMID: 18948611 Free PMC article. Clinical Trial.
Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors.
Collins P, Mosca L, Geiger MJ, Grady D, Kornitzer M, Amewou-Atisso MG, Effron MB, Dowsett SA, Barrett-Connor E, Wenger NK. Collins P, et al. Circulation. 2009 Feb 24;119(7):922-30. doi: 10.1161/CIRCULATIONAHA.108.817577. Epub 2009 Feb 9. Circulation. 2009. PMID: 19204301 Free PMC article. Clinical Trial.
Spotlight on gender.
Collins P, Stevenson JC, Mosca L. Collins P, et al. Cardiovasc Res. 2002 Feb 15;53(3):535-7. doi: 10.1016/s0008-6363(02)00224-9. Cardiovasc Res. 2002. PMID: 11861023 No abstract available.
Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002 : Section 4: lessons from hormone replacement trials.
Waters DD, Gordon D, Rossouw JE, Cannon RO 3rd, Collins P, Herrington DM, Hsia J, Langer R, Mosca L, Ouyang P, Sopko G, Stefanick ML; National Heart, Lung and Blood Institute; American College of Cardiology Foundation. Waters DD, et al. Among authors: collins p. Circulation. 2004 Feb 17;109(6):e53-5. doi: 10.1161/01.CIR.0000116209.25597.AE. Circulation. 2004. PMID: 14970126 No abstract available.
2,658 results